GE HealthCare Technologies Inc. $GEHC Shares Bought by Jennison Associates LLC

Jennison Associates LLC boosted its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 19.1% during the 1st quarter, according to its most recent filing with the SEC. The firm owned 695,019 shares of the company’s stock after purchasing an additional 111,434 shares during the period. Jennison Associates LLC’s holdings in GE HealthCare Technologies were worth $49,471,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of GEHC. Vanguard Group Inc. grew its holdings in GE HealthCare Technologies by 0.5% during the fourth quarter. Vanguard Group Inc. now owns 52,275,767 shares of the company’s stock worth $4,287,658,000 after acquiring an additional 267,058 shares during the period. Auto Owners Insurance Co boosted its position in GE HealthCare Technologies by 9,525.4% in the 4th quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company’s stock worth $278,725,000 after purchasing an additional 33,629,559 shares in the last quarter. Dodge & Cox boosted its position in GE HealthCare Technologies by 13.4% in the 4th quarter. Dodge & Cox now owns 31,211,229 shares of the company’s stock worth $2,559,945,000 after purchasing an additional 3,693,918 shares in the last quarter. Capital Research Global Investors grew its stake in shares of GE HealthCare Technologies by 1.6% during the 4th quarter. Capital Research Global Investors now owns 25,362,352 shares of the company’s stock worth $2,080,248,000 after purchasing an additional 389,796 shares during the period. Finally, State Street Corp grew its stake in shares of GE HealthCare Technologies by 2.0% during the 4th quarter. State Street Corp now owns 20,049,677 shares of the company’s stock worth $1,644,475,000 after purchasing an additional 401,932 shares during the period. Institutional investors and hedge funds own 82.06% of the company’s stock.

Insider Buying and Selling at GE HealthCare Technologies

In related news, CEO Peter J. Arduini bought 4,169 shares of the company’s stock in a transaction dated Thursday, April 30th. The shares were acquired at an average price of $59.92 per share, for a total transaction of $249,806.48. Following the completion of the transaction, the chief executive officer directly owned 259,424 shares in the company, valued at $15,544,686.08. This trade represents a 1.63% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Kevin Lobo bought 10,000 shares of the business’s stock in a transaction dated Friday, May 22nd. The shares were bought at an average cost of $64.18 per share, with a total value of $641,800.00. Following the purchase, the director directly owned 14,363 shares of the company’s stock, valued at approximately $921,817.34. This represents a 229.20% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Over the last quarter, insiders bought 21,847 shares of company stock valued at $1,361,355. Insiders own 0.36% of the company’s stock.

GE HealthCare Technologies Stock Performance

Shares of GEHC stock opened at $63.07 on Monday. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.22 and a quick ratio of 0.95. The company has a market cap of $28.69 billion, a price-to-earnings ratio of 15.09, a PEG ratio of 1.72 and a beta of 0.72. The stock has a 50 day simple moving average of $63.64 and a 200-day simple moving average of $71.89. GE HealthCare Technologies Inc. has a 1-year low of $58.75 and a 1-year high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). The business had revenue of $5.13 billion for the quarter, compared to analysts’ expectations of $5.04 billion. GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The company’s quarterly revenue was up 7.4% on a year-over-year basis. During the same quarter last year, the business earned $1.01 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. On average, equities research analysts expect that GE HealthCare Technologies Inc. will post 4.89 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Friday, July 24th will be issued a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend is Friday, July 24th. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.35%.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on GEHC shares. BNP Paribas Exane decreased their target price on shares of GE HealthCare Technologies from $95.00 to $88.00 in a research note on Friday, May 1st. Barclays dropped their price target on shares of GE HealthCare Technologies from $87.00 to $78.00 and set an “equal weight” rating on the stock in a research report on Thursday, April 30th. JPMorgan Chase & Co. cut their price objective on shares of GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating for the company in a report on Thursday, April 30th. UBS Group decreased their price objective on shares of GE HealthCare Technologies from $69.00 to $67.00 and set a “neutral” rating for the company in a research report on Thursday. Finally, Stifel Nicolaus set a $80.00 target price on shares of GE HealthCare Technologies in a research note on Wednesday, April 29th. Ten research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $76.41.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.